ProfileGDS5678 / 1445452_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 15% 18% 15% 71% 14% 15% 17% 17% 24% 18% 16% 18% 18% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3874415
GSM967853U87-EV human glioblastoma xenograft - Control 22.4309418
GSM967854U87-EV human glioblastoma xenograft - Control 32.3642815
GSM967855U87-EV human glioblastoma xenograft - Control 44.606171
GSM967856U87-EV human glioblastoma xenograft - Control 52.3057314
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4327315
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4324717
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4035817
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.5249724
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4226518
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3903416
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4201418
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4270518
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4211218